Business
MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada
HALIFAX, NS / ACCESS Newswire / February 25, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announce...
About this update from Medmira Inc.
[{"type":"text","content":"MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for CanadaHALIFAX, NS / ACCESS Newswire / February 25, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today its exclusive distribution agreement with Trimedic Inc. for the Canadian market. This partnership allows MedMira to expedite its growth in the Canadian market with the recently Health Canada approved Multiplo® TP/HIV rapid antibody test and its Reveal® G4 HIV-1/2 rapid antibody test. Both products have been granted Class 4 Medical Device Licenses, the highest regulatory classification for medical diagnostics in Canada.Trimedic Inc. is a leading supplier and distributor of medical supplies in Canada since 1986. As one of Canada's largest providers of point-of-care diagnostic, Trimedic is focused on expanding access to laboratory quality tests at point-of-care. Ultimately reducing the wait times to receive accurate results to key health indicators. Trimedic's key strategy is to enable a decentralize diagnostic testing and disease monitoring.\"With the recent Health Canada approvals for our Multiplo® TP/HIV and Reveal® G4 HIV rapid tests, we are excited to bring fast and reliable testing solutions to Canada, addressing an urgent need in the market. As we prepare for the upcoming approvals of new and innovative products, particularly our unique syphilis tests, it is essential to have an experienced and focused distribution partner. Trimedic, with its knowledgeable team and well-established network, is the ideal partner to support MedMira's growth and expansion in Canada.\" said Hermes Chan, CEO of MedMira. \"This partnership allows us to expand in the growing STI rapid test market while enabling MedMira to focus on its core strengths, including product development, regulatory compliance, and manufacturing.\"Trimedic has been a pioneer in various point-of-care products such as in the field of harm reduction and women's health which are key markets for MedMira's product portfolio. With the already approved products on hand and a number of additional products in the review process and clinical trials, we expect to further expand on our offering. As a result this partnership can further contribute to provide high quality rapid tests in Canada.The latest data from the Public Health Agency of Canada, shows that new HIV diagnoses soared more...